Company
Clinical stage start-up developing diagnostic products for patients with life-threatening immune deficiencies.
Every investor coverage indicates participated in a round Immunosis raised.
Companies Immunosis acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Immunosis. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A profile of six life-science ventures that graduated from Melbourne bioincubator Jumar's debut program, one of which, Tessara Therapeutics, won a $3 million research grant in December.
Five Australian digital health startups received a combined $3.25 million in stage-two grant funding from the Medical Research Future Fund, facilitated by ANDHealth.